Activation of Rac1 is closely related to androgen-independent cell proliferation of prostate cancer cells both in vitro and in vivo.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Molecular Endocrinology

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/me.2009-0326PMID 20203103PMCID PMC5417531
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer.

  2009cited by this paper
• Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

  2009cited by this paper
• Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530

  2008cited by this paper
• Nonreceptor tyrosine kinases in prostate cancer.

  2007cited by this paper
• Roles of androgen-dependent and -independent activation of signal transduction pathways for cell proliferation of prostate cancer cells

  2007cited by this paper
• Prognostic relevance of increased Rac GTPase expression in prostate carcinomas.

  2007cited by this paper
• PAK1 hyperactivation is sufficient for mammary gland tumor formation

  2006cited by this paper
• cAMP-induced PKC activation increases functional CXCR4 expression on human CD34 hematopoietic progenitors

  2006cited by this paper
• p21-activated kinases in cancer

  2006cited by this paper
• Requirement of androgen-dependent activation of protein kinase Czeta for androgen-dependent cell proliferation in LNCaP Cells and its roles in transition to androgen-independent cells.

  2006cited by this paper
• Inappropriate activation of the androgen receptor by nonsteroids: involvement of the Src kinase pathway and its therapeutic implications.

  2006cited by this paper
• Cancer Statistics, 2006

  2006cited by this paper
• Epithelial-Restricted Gene Profile of Primary Cultures from Human Prostate Tumors: A Molecular Approach to Predict Clinical Behavior of Prostate Cancer

  2006cited by this paper
• Prognostic relevance of Tiam1 protein expression in prostate carcinomas

  2006cited by this paper
• Regulation of androgen receptor activity by tyrosine phosphorylation.

  2006cited by this paper
• The role of focal-adhesion kinase in cancer — a new therapeutic opportunity

  2005cited by this paper
• Post-transcriptional regulation of the androgen receptor by Mammalian target of rapamycin.

  2005cited by this paper
• Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells.

  2005cited by this paper
• Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient.

  2005cited by this paper
• Local phosphatidylinositol 3,4,5-trisphosphate accumulation recruits Vav2 and Vav3 to activate Rac1/Cdc42 and initiate neurite outgrowth in nerve growth factor-stimulated PC12 cells.

  2005cited by this paper
• Myocardial subproteomic analysis of a constitutively active Rac1-expressing transgenic mouse with lethal myocardial hypertrophy.

  2005cited by this paper
• The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer.

  2005cited by this paper
• Stem Cell Depletion Through Epidermal Deletion of Rac1

  2005cited by this paper
• Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population.

  2005cited by this paper
• Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.

  2005cited by this paper
• Cell lines used in prostate cancer research: a compendium of old and new lines--part 1.

  2005cited by this paper
• Rapid signalling pathway activation by androgens in epithelial and stromal cells.

  2004cited by this paper
• Rational design and characterization of a Rac GTPase-specific small molecule inhibitor.

  2004cited by this paper
• Overexpression of Rac-1 small GTPase binding protein in oral squamous cell carcinoma.

  2004cited by this paper
• Changes in Androgen Receptor Nongenotropic Signaling Correlate with Transition of LNCaP Cells to Androgen Independence

  2004cited by this paper
• Androgen receptor in prostate cancer.

  2004cited by this paper
• Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21CIP1 levels in androgen-independent human prostate cancer cells

  2004cited by this paper
• A renaissance for SRC

  2004cited by this paper
• Rac1 Function Is Required for Src-induced Transformation

  2003cited by this paper
• Protein kinase C lambda/iota (PKClambda/iota): a PKC isotype essential for the development of multicellular organisms.

  2003cited by this paper
• Protein Kinase C λ/ι (PKCλ/ι): A PKC Isotype Essential for the Development of Multicellular Organisms

  2003cited by this paper
• Rho GTPases in transformation and metastasis.

  2002cited by this paper
• The role of Rho GTPases in disease development.

  2002cited by this paper
• Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.

  2002cited by this paper
• NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer.

  2002cited by this paper
• RHO–GTPases and cancer

  2002cited by this paper
• Role of MLK3-mediated Activation of p70 S6 Kinase in Rac1 Transformation*

  2002cited by this paper
• Rho GTPases in cell biology

  2002cited by this paper
• Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein.

  2002cited by this paper
• NF-κB Activates Prostate-Specific Antigen Expression and Is Upregulated in Androgen-Independent Prostate Cancer

  2002cited by this paper
• Human homologues of the Caenorhabditis elegans cell polarity protein PAR6 as an adaptor that links the small GTPases Rac and Cdc42 to atypical protein kinase C

  2001cited by this paper
• Dbl and the Rho GTPases Activate NFκB by IκB Kinase (IKK)-dependent and IKK-independent Pathways*

  2001cited by this paper
• Vav2 is required for cell spreading

  2001cited by this paper
• Dbl and the Rho GTPases activate NF kappa B by I kappa B kinase (IKK)-dependent and IKK-independent pathways.

  2001cited by this paper
• Coordination of cell polarization and migration by the Rho family GTPases requires Src tyrosine kinase activity.

  2001cited by this paper
• Steroid‐induced androgen receptor–oestradiol receptor β–Src complex triggers prostate cancer cell proliferation

  2000cited by this paper
• Ras and Rho GTPases: a family reunion.

  2000cited by this paper
• Rac1 mutations produce aberrant epithelial differentiation in the developing and adult mouse small intestine.

  2000cited by this paper
• Apoptosis, p53, and tumor cell sensitivity to anticancer agents.

  1999cited by this paper
• The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes.

  1998cited by this paper
• Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells.

  1998cited by this paper
• Rho GTPases and signaling networks.

  1997cited by this paper
• Ki67 LABELLING INDEX: AN INDEPENDENT PREDICTOR OF PROGRESSION IN PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY

  1996cited by this paper
• The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1.

  1996cited by this paper
• The small GTP-binding protein rac regulates growth factor-induced membrane ruffling.

  1992cited by this paper
• The transforming proteins of Rous sarcoma virus, Harvey sarcoma virus and Abelson virus contain tightly bound lipid.

  1982cited by this paper
• Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.

  1941cited by this paper

• РОЛЬ микроРНК В РАЗВИТИИ АГРЕССИВНЫХ ФОРМ РАКА ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ, "Наука юга России"

  2023cites this paper
• Newly developed preclinical models reveal broad‐spectrum CDK inhibitors as potent drugs for CRPC exhibiting primary resistance to enzalutamide

  2023cites this paper
• Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1

  2022cites this paper
• Insulin stimulates atypical protein kinase C‐mediated phosphorylation of the neuronal adaptor FE65 to potentiate neurite outgrowth by activating ARF6‐Rac1 signaling

  2022cites this paper
• Hormone-Dependent Prostate Cancers are Dependent on Rac Signaling for Growth and Survival

  2021cites this paper
• Androgen deprivation-induced OPHN1 amplification promotes castration-resistant prostate cancer

  2021cites this paper
• Regulatory mechanism of androgen receptor on NCAPD3 gene expression in prostate cancer

  2021cites this paper
• Title: Hormone dependent prostate cancers are dependent on Rac signaling for growth and survival Running Title: Rac signaling drives prostate cancer

  2021cites this paper
• MicroRNAs in treatment-induced neuroendocrine differentiation in prostate cancer

  2020cites this paper
• Effects of Arf6 downregulation on biological characteristics of human prostate cancer cells

  2020cites this paper
• P-REX1-Independent, Calcium-Dependent RAC1 Hyperactivation in Prostate Cancer

  2020cites this paper
• Active RAC1 Promotes Tumorigenic Phenotypes and Therapy Resistance in Solid Tumors

  2020cites this paper
• AZGP1 is androgen responsive and involved in AR‐induced prostate cancer cell proliferation and metastasis

  2019cites this paper
• RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma

  2019cites this paper
• Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies

  2019cites this paper
• Androgen receptor: what we know and what we expect in castration-resistant prostate cancer

  2018cites this paper
• p66Shc regulates migration of castration-resistant prostate cancer cells.

  2018cites this paper
• Role of MicroRNAs in Treatment Response in Prostate Cancer

  2018cites this paper
• THE ROLE OF RAC IN TUMOUR SUSCEPTIBILITY AND DISEASE PROGRESSION: FROM BIOCHEMISTRY TO THE CLINIC

  2018cites this paper
• The role of Rac in tumor susceptibility and disease progression: from biochemistry to the clinic.

  2018cites this paper
• Inhibiting geranylgeranyl diphosphate synthesis reduces nuclear androgen receptor signaling and neuroendocrine differentiation in prostate cancer cell models

  2018cites this paper
• IRS-2 deubiquitination by USP9X maintains anchorage-independent cell growth via Erk1/2 activation in prostate carcinoma cell line

  2018cites this paper
• CXCL13 is androgen-responsive and involved in androgen induced prostate cancer cell migration and invasion

  2017cites this paper
• CXCL13 is androgen-responsive and involved in androgen induced prostate cancer cell migration and invasion.

  2017cites this paper
• P-Rex1 Promotes Resistance to VEGF/VEGFR-Targeted Therapy in Prostate Cancer.

  2016cites this paper
• P-Rex 1 Promotes Resistan ce to VEGF / VEGFR-Targeted Therapy in Prostate Cancer Graphical

  2016cites this paper
• P-Rex 1 Promotes Resistance to VEGF / VEGFR-Targeted Therapy in Prostate Cancer

  2016cites this paper
• Targeting protein geranylgeranylation slows tumor development in a murine model of prostate cancer metastasis

  2016cites this paper
• Mediating Prostate Cancer Metastasis Through the MicroRNA Cluster MiR-23b/-27b

  2016cites this paper
• In Vitro Analysis for the use of Honey Bee Products in the Treatment of Metastatic Prostate Cancer

  2015cites this paper
• Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment

  2015cites this paper
• Rac1-Dependent Lamellipodial Motility in Prostate Cancer PC-3 Cells Revealed by Optogenetic Control of Rac1 Activity

  2014cites this paper
• Increased aPKC Expression Correlates with Prostatic Adenocarcinoma Gleason Score and Tumor Stage in the Japanese Population

  2014cites this paper
• Atypical protein kinase Cι as a human oncogene and therapeutic target.

  2014cites this paper
• AWARD NUMBER: W81XWH-12-1-0308 TITLE: Neuropilin-2: Novel Biomarker and Therapeutic Target for Aggressive Prostate Cancer PRINCIPAL INVESTIGATOR:

  2014cites this paper
• The role of microRNA in castration-resistant prostate cancer.

  2014cites this paper
• Cell Death and Survival PPP 2 R 2 C Loss Promotes Castration-Resistance and Is Associated with Increased Prostate Cancer-Speci fi c Mortality

  2013cites this paper
• Apocynin, an NADPH oxidase inhibitor, suppresses progression of prostate cancer via Rac1 dephosphorylation.

  2013cites this paper
• Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma

  2013cites this paper
• Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer

  2013cites this paper
• The role of Y-box binding protein 1 in prostate cancer

  2013cites this paper
• Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer

  2013cites this paper
• MiR-23b/-27b Cluster Suppresses the Metastatic Phenotype of Aggressive Prostate Cancer Cells

  2013cites this paper
• Effect of Rac1 downregulation mediated by shRNA on the biological behaviour of human cervical cancer cells

  2013cites this paper
• Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids

  2013influential citation
• PPP2R2C Loss Promotes Castration-Resistance and Is Associated with Increased Prostate Cancer-Specific Mortality

  2013cites this paper
• Bypassing androgen pathway dependence in advanced prostate cancer.

  2012cites this paper
• RhoC and guanine nucleotide exchange factor Net1 in androgen‐unresponsive mouse mammary carcinoma SC‐4 cells and human prostate cancer after short‐term endocrine therapy

  2012cites this paper
• Hyaluronan (HA) Interacting Proteins RHAMM and Hyaluronidase Impact Prostate Cancer Cell Behavior and Invadopodia Formation in 3D HA-Based Hydrogels

  2012cites this paper
• β2-syntrophin and Par-3 promote an apicobasal Rac activity gradient at cell-cell junctions by differentially regulating Tiam1 activity

  2012cites this paper
• Traditional Chinese medicine as dual guardians against hypertension and cancer?

  2012cites this paper
• The microRNA -23b/-27b Cluster Suppresses the Metastatic Phenotype of Castration-Resistant Prostate Cancer Cells

  2012cites this paper
• CaM kinase kinase beta-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells.

  2011cites this paper
• Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer

  2011influential citation